<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1405-0099</journal-id>
<journal-title><![CDATA[Cirujano general]]></journal-title>
<abbrev-journal-title><![CDATA[Cir. gen]]></abbrev-journal-title>
<issn>1405-0099</issn>
<publisher>
<publisher-name><![CDATA[Asociación Mexicana de Cirugía General A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1405-00992015000100038</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Tratamiento actual de la enfermedad por reflujo gastroesofágico]]></article-title>
<article-title xml:lang="en"><![CDATA[Current treatment of gastroesophageal reflux disease]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González-Izquierdo]]></surname>
<given-names><![CDATA[José de Jesús]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández-Aguilar]]></surname>
<given-names><![CDATA[Tulio Jesús]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Palomares-Chacón]]></surname>
<given-names><![CDATA[Ulises Rodrigo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Castelltor Hernández]]></surname>
<given-names><![CDATA[Luis Fernando]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez Navarro]]></surname>
<given-names><![CDATA[José Víctor]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Anaya-Prado]]></surname>
<given-names><![CDATA[Roberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Unidad de Atención Médica ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,IMSS Centro Médico Nacional de Occidente Unidad Médica de Alta Especialidad Hospital de Especialidades (UMAE-HE)]]></institution>
<addr-line><![CDATA[Guadalajara Jalisco]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Centro Médico Nacional de Occidente Hospital de Ginecología y Obstetricia]]></institution>
<addr-line><![CDATA[Guadalajara Jalisco]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2015</year>
</pub-date>
<volume>37</volume>
<numero>1-2</numero>
<fpage>38</fpage>
<lpage>43</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1405-00992015000100038&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1405-00992015000100038&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1405-00992015000100038&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: La enfermedad por reflujo gastroesofágico se define como una falla de la barrera antirreflujo que determina un paso anormal de secreciones digestivas altas al esófago y produce síntomas con daño esofágico y extraesofágico. Los mecanismos fisiológicos que impiden el reflujo son el aclaramiento, el esfínter esofágico inferior y el vaciamiento gástrico adecuado. El fracaso en estos mecanismos de defensa permite el reflujo gastroesofágico. El tratamiento quirúrgico de la enfermedad por reflujo gastroesofágico ha estado en constante evolución durante los últimos 70 años. La funduplicatura de Nissen, la de Belsey y la gastropexia de Hill han sido estudiadas y modificadas con el paso del tiempo; se han realizado diferentes tipos de abordajes. Un tratamiento efectivo es reducir la secreción ácida del estómago, bien sea con antagonistas de los receptores H2, bien con inhibidores de la bomba de protones; la dosis dependerá de la severidad de cada paciente, ya que cuanto mayor sea la exposición esofágica al ácido, mayor será el grado de supresión que se requerirá para sanar. Actualmente existe mucho debate en cuanto a los beneficios del tratamiento médico frente al quirúrgico y el papel de la laparoscopia como cirugía de primer tiempo o como segundo abordaje. El objetivo de este artículo es determinar las opciones terapéuticas quirúrgicas y médicas que tenemos actualmente en nuestro medio.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: Gastroesophageal reflux disease is defined as a failure of the anti-reflux barrier that leads to abnormally high digestive secretions passing into the esophagus, which produces symptoms of esophageal and extra-esophageal damage. The physiological mechanisms that prevent reflux are clearance, the lower esophageal sphincter and the right gastric emptying. Failure in these defense mechanisms leads to gastroesophageal reflux. Surgical treatment of gastroesophageal reflux disease has been in constant evolution over the past 70 years. Nissen fundoplication, Belsey&#8217;s and Hill gastropexy have been studied and modified over time, and with different approaches. An effective treatment is to reduce acid secretion of the stomach with either an H2 receptor antagonist or a proton pump inhibitor. The dose depends on the severity of each patient: the greater the esophageal exposure to acid, the greater will be the degree of suppression required to cure it. There is currently much debate about the benefits of the medical or surgical treatments, and the role of laparoscopic surgery as a first-time or second approach. The objective of this paper is to determine the surgical and medical treatment options currently available.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Enfermedad por reflujo gastroesofágico]]></kwd>
<kwd lng="es"><![CDATA[funduplicatura]]></kwd>
<kwd lng="es"><![CDATA[inhibidor de la bomba de protones]]></kwd>
<kwd lng="en"><![CDATA[Gastroesophageal reflux disease]]></kwd>
<kwd lng="en"><![CDATA[fundoplication]]></kwd>
<kwd lng="en"><![CDATA[proton pump inhibitor]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Christian]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Buyske]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Current status of antireflux surgery]]></article-title>
<source><![CDATA[Surg Clin North Am]]></source>
<year>2005</year>
<volume>85</volume>
<page-range>931-47</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kahrilas]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gastroesophageal reflux disease]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>1996</year>
<volume>276</volume>
<page-range>983-8</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hirschowitz]]></surname>
<given-names><![CDATA[BI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of refractory and complicated reflux esophagitis]]></article-title>
<source><![CDATA[Yale J Biol Med]]></source>
<year>1996</year>
<volume>69</volume>
<page-range>271-81</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[El-Serag]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Hill]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Systematic review: The epidemiology of gastro-oesophageal reflux disease in primary care, using the UK general practice research database]]></article-title>
<source><![CDATA[Aliment Pharmacol Ther]]></source>
<year>2009</year>
<volume>5</volume>
<page-range>470-80</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dent]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[El-Serag]]></surname>
<given-names><![CDATA[HB]]></given-names>
</name>
<name>
<surname><![CDATA[Wallander]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of gastro-oesophageal reflux disease: A systematic review]]></article-title>
<source><![CDATA[Gut]]></source>
<year>2005</year>
<volume>54</volume>
<page-range>710-7</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bainbridge]]></surname>
<given-names><![CDATA[ET]]></given-names>
</name>
<name>
<surname><![CDATA[Temple]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Nicholas]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Symptomatic gastro-oesophageal reflux in pregnancy: a comparative study of white Europeans and Asians in Birmingham]]></article-title>
<source><![CDATA[Br J Clin Pract]]></source>
<year>1983</year>
<volume>37</volume>
<page-range>53-7</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mittal]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Holloway]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Penagini]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Transient lower esophageal sphincter relaxation]]></article-title>
<source><![CDATA[Gastroenterology]]></source>
<year>1995</year>
<volume>109</volume>
<page-range>601-10</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dent]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Dodds]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Friedman]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects]]></article-title>
<source><![CDATA[J Clin Invest]]></source>
<year>1980</year>
<volume>65</volume>
<page-range>256-67</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vakil]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[van Zanten]]></surname>
<given-names><![CDATA[SV]]></given-names>
</name>
<name>
<surname><![CDATA[Kahrilas]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus]]></article-title>
<collab>Global Consensus Group</collab>
<source><![CDATA[Am J Gastroenterol]]></source>
<year>2006</year>
<volume>101</volume>
<page-range>1900-quiz 1943</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kahrilas]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Anatomy and physiology of the gastroesophageal function]]></article-title>
<source><![CDATA[Gastroenterol Clin North Am]]></source>
<year>1997</year>
<volume>26</volume>
<page-range>467-86</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Richards]]></surname>
<given-names><![CDATA[WG]]></given-names>
</name>
<name>
<surname><![CDATA[Sugarbaker]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neuronal control of esophageal function]]></article-title>
<source><![CDATA[Chest Surg Clin N Am]]></source>
<year>1995</year>
<volume>5</volume>
<page-range>157-71</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lundell]]></surname>
<given-names><![CDATA[LR]]></given-names>
</name>
<name>
<surname><![CDATA[Dent]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bennett]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification]]></article-title>
<source><![CDATA[Gut]]></source>
<year>1999</year>
<volume>45</volume>
<page-range>172-80</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zerbib]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Roman]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ropert]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy]]></article-title>
<source><![CDATA[Am J Gastroenterol]]></source>
<year>2006</year>
<volume>101</volume>
<page-range>1956-63</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hemmink]]></surname>
<given-names><![CDATA[GJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bredenoord]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Weusten]]></surname>
<given-names><![CDATA[BL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: &#8216;on&#8217; or &#8216;off&#8217; proton pump inhibitor?]]></article-title>
<source><![CDATA[Am J Gastroenterol]]></source>
<year>2008</year>
<volume>103</volume>
<page-range>2446-53</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kitchin]]></surname>
<given-names><![CDATA[LI]]></given-names>
</name>
<name>
<surname><![CDATA[Castell]]></surname>
<given-names><![CDATA[DO]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rationale and efficacy of conservative therapy for gastroesophageal reflux disease]]></article-title>
<source><![CDATA[Arch Intern Med]]></source>
<year>1991</year>
<volume>151</volume>
<page-range>448-54</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bell]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Hunt]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Role of gastric acid suppression in the treatment of gastroesophageal reflux disease]]></article-title>
<source><![CDATA[Gut]]></source>
<year>1992</year>
<volume>33</volume>
<page-range>118-24</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Harvey]]></surname>
<given-names><![CDATA[RF]]></given-names>
</name>
<name>
<surname><![CDATA[Gordon]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
<name>
<surname><![CDATA[Hadley]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of sleeping with the bedhead raised and of ranitidine in patients with severe peptic oesophagitis]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1987</year>
<volume>2</volume>
<page-range>1200-3</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[DeVault]]></surname>
<given-names><![CDATA[KR]]></given-names>
</name>
<name>
<surname><![CDATA[Castell]]></surname>
<given-names><![CDATA[DO]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease]]></article-title>
<collab>American College of Gastroenterology</collab>
<source><![CDATA[Am J Gastroenterol]]></source>
<year>2005</year>
<volume>100</volume>
<page-range>190-200</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mathias]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Colwell]]></surname>
<given-names><![CDATA[HH]]></given-names>
</name>
<name>
<surname><![CDATA[Miller]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Health-related quality-of-life and quality-days incrementally gained in symptomatic none rosive GERD patients treated with lansoprazole or ranitidine]]></article-title>
<source><![CDATA[Dig Dis Sci]]></source>
<year>2001</year>
<volume>46</volume>
<page-range>2416-23</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sontag]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The medical management of reflux esophagitis. Role of antacids and acid inhibition]]></article-title>
<source><![CDATA[Gastroenterol Clin North Am]]></source>
<year>1990</year>
<volume>19</volume>
<page-range>683-712</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Savarino]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Dulbecco]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Optimizing symptom relief and preventing complications in adults with gastro-oesophageal reflux disease]]></article-title>
<source><![CDATA[Digestion]]></source>
<year>2004</year>
<volume>69</volume>
<page-range>9-16</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Becher]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[El-Serag]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease]]></article-title>
<source><![CDATA[Aliment Pharmacol Ther]]></source>
<year>2011</year>
<volume>34</volume>
<page-range>618-27</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lind]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Havelund]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Carlsson]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Heartburn without esophagitis: efficacy of omeprazole therapy and features determining therapeutic response]]></article-title>
<source><![CDATA[Scand J Gastroenterol]]></source>
<year>1997</year>
<volume>32</volume>
<page-range>974-9</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hatlebakk]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Berstad]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Carling]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lansoprazole versus omeprazole in short-term treatment of reflux esophagitis: results of a Scandinavian multicentre trial]]></article-title>
<source><![CDATA[Scand J Gastroenterol]]></source>
<year>1993</year>
<volume>28</volume>
<page-range>224-8</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Feldman]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Harford]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Fisher]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment of reflux esophagitis resistant to H2 receptor antagonists with lansoprazolea new H+/K sup+-ATPase inhibitor: a controlled, double-blind study]]></article-title>
<source><![CDATA[Am J Gastroenterol]]></source>
<year>1993</year>
<volume>88</volume>
<page-range>1212-7</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Klinkenberg-Knol]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Festen]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Jansen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Long term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety]]></article-title>
<source><![CDATA[Ann Intern Med]]></source>
<year>1994</year>
<volume>121</volume>
<page-range>161-7</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Richter]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Long]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cisapride for gastroesophageal reflux disease: a placebo-controlled, double blind study]]></article-title>
<source><![CDATA[Am J Gastroenterol]]></source>
<year>1995</year>
<volume>90</volume>
<page-range>423-30</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Galmiche]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Brandsatter]]></surname>
</name>
<name>
<surname><![CDATA[Evreux]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Combined therapy with cisapride and cimetidine in severe oesophagitis: a double blind controlled trial]]></article-title>
<source><![CDATA[Gut]]></source>
<year>1988</year>
<volume>29</volume>
<page-range>675-81</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Catarci]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gentileschi]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Papi]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evidence-based appraisal of anti-reflux fundoplication]]></article-title>
<source><![CDATA[Ann Surg]]></source>
<year>2004</year>
<volume>239</volume>
<page-range>325-37</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Metz]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Long-term outcome of laparoscopic Nissen and laparoscopic Toupet fundoplication for gastroesopahgeal reflux disease: a prospective, randomized trial]]></article-title>
<source><![CDATA[Surg Endosc]]></source>
<year>2011</year>
<volume>24</volume>
<page-range>924-32</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nijjar]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Watson]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Jamieson]]></surname>
<given-names><![CDATA[GG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Five-year follow-up of a multicenter, double-blind randomized clinical trial of laparoscopic Nissen vs anterior 90 degrees partial fundoplication]]></article-title>
<source><![CDATA[Arch Surg]]></source>
<year>2010</year>
<volume>145</volume>
<page-range>552-7</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Markar]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
<name>
<surname><![CDATA[Karthikesalingam]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Wagner]]></surname>
<given-names><![CDATA[OJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Systematic review and meta-analysis of laparoscopic Nissen fundoplication with or without division of the short gastric vessels]]></article-title>
<source><![CDATA[Br J Surg]]></source>
<year>2011</year>
<volume>98</volume>
<page-range>1056-62</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Koch]]></surname>
<given-names><![CDATA[OO]]></given-names>
</name>
<name>
<surname><![CDATA[Kaindlstorfer]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Antoniou]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Laparoscopic Nissen versus Toupet fundoplication: objective and subjective results of a prospective randomized trial]]></article-title>
<source><![CDATA[Surg Endosc]]></source>
<year>2012</year>
<volume>26</volume>
<page-range>413-22</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oelschlager]]></surname>
<given-names><![CDATA[BK]]></given-names>
</name>
<name>
<surname><![CDATA[Petersen]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
<name>
<surname><![CDATA[Brunt]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Laparoscopic paraesophageal hernia repair: Defining long-term clinical and anatomic outcomes]]></article-title>
<source><![CDATA[J Gastrointest Surg]]></source>
<year>2012</year>
<volume>16</volume>
<page-range>453-9</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Attwood]]></surname>
<given-names><![CDATA[SEA]]></given-names>
</name>
<name>
<surname><![CDATA[Lundell]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Ell]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Standardization of surgical technique in antireflux surgery: the LOTUS trial experience]]></article-title>
<source><![CDATA[World J Surg]]></source>
<year>2008</year>
<volume>32</volume>
<page-range>995-58</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Anvari]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Allen]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Marshall]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for treatment of patients with chronic gastroesophageal reflux disease: one-year follow-up]]></article-title>
<source><![CDATA[Surg Innov]]></source>
<year>2006</year>
<volume>13</volume>
<page-range>238-49</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hunter]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[CD]]></given-names>
</name>
<name>
<surname><![CDATA[Branum]]></surname>
<given-names><![CDATA[GD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Laparoscopic fundoplication failures: patterns of failure and response to fundoplication revision]]></article-title>
<source><![CDATA[Ann Surg]]></source>
<year>1999</year>
<volume>230</volume>
<page-range>595-604</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Willeman]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[McCann]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Grant]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults]]></article-title>
<source><![CDATA[Cochrane Database Syst Rev]]></source>
<year>2010</year>
<volume>17</volume>
<page-range>CD003243</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Attwood]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Lundell]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Hatlebakk]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medical or surgical management of GERD patients with Barrett&#8217;s esophagus: The LOTUS trial 3-year experience]]></article-title>
<source><![CDATA[J Gastrointest Surg]]></source>
<year>2008</year>
<volume>12</volume>
<page-range>1646-54</page-range></nlm-citation>
</ref>
<ref id="B40">
<label>40</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lundell]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Attwood]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ell]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastrooesophageal reflux disease: a 3-year interim analysis of the LOTUS trial]]></article-title>
<source><![CDATA[Gut]]></source>
<year>2008</year>
<volume>57</volume>
<page-range>1207-13</page-range></nlm-citation>
</ref>
<ref id="B41">
<label>41</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cookson]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Flood]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Koo]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Short-term cost effectiveness and long-term cost analysis comparing laparoscopic Nissen fundoplication with proton pump inhibitor maintenance for gastro-oesophageal reflux disease]]></article-title>
<source><![CDATA[Br J Surg]]></source>
<year>2005</year>
<volume>92</volume>
<page-range>700-6</page-range></nlm-citation>
</ref>
<ref id="B42">
<label>42</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Decadt]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Lowndes]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rhodes]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prospective randomized trial of laparoscopic Nissen fundoplication (LNF) versus maintenance proton pump inhibition (PPI) in the treatment of gastro-oesophageal reflux disease (GORD): manometric findings]]></article-title>
<source><![CDATA[Gastroenterology]]></source>
<year>1999</year>
<volume>116</volume>
<page-range>A146</page-range></nlm-citation>
</ref>
<ref id="B43">
<label>43</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grant]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Wileman]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ramsay]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease -a UK collaborative study. The REFLUX trial]]></article-title>
<source><![CDATA[Health Technol Assess]]></source>
<year>2008</year>
<volume>12</volume>
<page-range>1-iii-iv</page-range></nlm-citation>
</ref>
<ref id="B44">
<label>44</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grant]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Wileman]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Ramsay]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Minimal access surgery compared with medical management for chronic gastro-oesophageal reflux disease: UK collaborative randomised trial]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2008</year>
<volume>337</volume>
<page-range>a2664</page-range></nlm-citation>
</ref>
<ref id="B45">
<label>45</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Metha]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bennett]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mahon]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prospective trial of laparoscopic Nissen fundoplication versus proton pump inhibitor therapy for gastroesophageal reflux disease: Seven-year follow-up]]></article-title>
<source><![CDATA[J Gastrointest Surg]]></source>
<year>2006</year>
<volume>10</volume>
<page-range>1312-7</page-range></nlm-citation>
</ref>
<ref id="B46">
<label>46</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Anvari]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Allen]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Marshall]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for the treatment of patients with chronic gastrooesophageal reflux disease (GERD): 3 year outcomes]]></article-title>
<source><![CDATA[Surg Endosc]]></source>
<year>2011</year>
<volume>25</volume>
<page-range>2547-54</page-range></nlm-citation>
</ref>
<ref id="B47">
<label>47</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Faria]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bojke]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Epstein]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cost effectiveness of laparoscopic fundoplication versus continued medical management for the treatment of GERD based on long-term follow-up of the REFLUX trial]]></article-title>
<source><![CDATA[Br J Surg]]></source>
<year>2013</year>
<volume>100</volume>
<page-range>1205-13</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
